Annals of Oncology

News:

EHA doubles its bets
Ann Oncol 10: 867.
[PDF] [Request Permissions]

Lymphoma festival in Lugano
Ann Oncol 10: 867-868.
[PDF] [Request Permissions]

WHO cares about cancer?
Ann Oncol 10: 868-869.
[PDF] [Request Permissions]

France hints at less repression
Ann Oncol 10: 869.
[PDF] [Request Permissions]

What after Crozemarie?
Ann Oncol 10: 869-870.
[PDF] [Request Permissions]

Too little control over biological research, say the British
Ann Oncol 10: 870.
[PDF] [Request Permissions]

How many breast conferences do we need?
Ann Oncol 10: 870-871.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 10: 871-873.
[PDF] [Request Permissions]

Book reviews:

G. Giaccone

Book review
Ann Oncol 10: 874-875.
[PDF] [Request Permissions]

M. Tattersall

Book review
Ann Oncol 10: 1000.
[PDF] [Request Permissions]

Editorial:

A. Santoro, M. Balzarotti, and L. Castagna

Intensified CHOP in non-Hodgkin's lymphoma: What we know and what we need to know
Ann Oncol 10: 875-876.
[PDF] [Request Permissions]

C. H. Koehne, R. Midgley, M. Seymour, and D. J. Kerr

Advanced colorectal cancer: Which regimes should we recommend?
Ann Oncol 10: 877-882.
[PDF] [Request Permissions]

Review:

F. A. Vicini, N. S. Goldstein, and L. L. Kestin

Pathologic and technical considerations in the treatment of ductal carcinoma in situ of the breast with lumpectomy and radiation therapy
Ann Oncol 10: 883-890.
[Abstract] [PDF] [Request Permissions]

H. Kuyu, W. R. Lee, R. Bare, M. C. Hall, and F. M. Torti

Recent advances in the treatment of prostate cancer
Ann Oncol 10: 891-898.
[Abstract] [PDF] [Request Permissions]

Commentary:

A. Kiss and Organizing Committee

Communication skills training in oncology: A position paper
Ann Oncol 10: 899-901.
[PDF] [Request Permissions]

Arena:

J. Crown, B. Coiffier, H. Cortés-Funes, Th. Guillaume, L. Kanz, G. Kvalheim, M. Marty, and M. Symann

ESTIC position paper: High-dose chemotherapy for breast cancer, investigation should continue
Ann Oncol 10: 903-905.
[PDF] [Request Permissions]

Original articles:

S.M. Talbot, D.A. Westerman, A.P. Grigg, G.C. Toner, M. Wolf, J. Bishop, J. McKendrick, J. Zalcberg, J. Levi, R.M. Fox, and M.D. Green

Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors
Ann Oncol 10: 907-914.
[Abstract] [PDF] [Request Permissions]

P. Comella, R. Casaretti, F. De Vita, A. Avallone, M. Orditura, A. Petrillo, A. Gravina, A. Faranda, S. Comis, G. Comella, and G. Catalano

Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: A phase I study of the Southern Italy Cooperative Oncology Group
Ann Oncol 10: 915-921.
[Abstract] [PDF] [Request Permissions]

D. J. Propper, J. P. Braybrooke, D. J. Taylor, R. Lodi, P. Styles, J. A. Cramer, W. C. J. Collins, N. C. Levitt, D. C. Talbot, T. S. Ganesan, and A. L. Harris

Phase I trial of the selective mitochondrial toxin MKT 077 in chemo-resistant solid tumours
Ann Oncol 10: 923-927.
[Abstract] [PDF] [Request Permissions]

H. C. F. Moore, R. Mick, L. J. Solin, C. Sickles, P. A. Mangan, S. M. Luger, K. R. Fox, L. M. Schuchter, E. Loh, D. L. Porter, S. Schuster, G. P. Buzby, E. Glatstein, L. E. Silberstein, and E. A. Stadtmauer

Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: Impact on the delivery of local-regional radiation therapy
Ann Oncol 10: 929-936.
[Abstract] [PDF] [Request Permissions]

C. Nisticò, C. Garufi, S. Barni, L. Frontini, D. A. P. Gallà, D. Giannarelli, A. Vaccaro, A. M. D'Ottavio, and E. Terzoli

Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: A high-activity, dose-dense weekly regimen for advanced breast cancer
Ann Oncol 10: 937-942.
[Abstract] [PDF] [Request Permissions]

M. L. Dunsford, G. M. Mead, A. C. Bateman, T. Cook, and K. Tung

Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma
Ann Oncol 10: 943-947.
[Abstract] [PDF] [Request Permissions]

A. M. Codegoni, F. Bertoni, C. Patregnani, E. Marinetti, M. D'Incalci, and M. Broggini

Allelic expression of p73 in human ovarian cancers
Ann Oncol 10: 949-953.
[Abstract] [PDF] [Request Permissions]

D. Seong, H.M. Kantarjian, M. Albitar, R. Arlinghaus, J. Xu, M. Talpaz, M. B. Rios, J. Qiang Guo, S. O'Brien, and M. Siciliano

Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization
Ann Oncol 10: 955-959.
[Abstract] [PDF] [Request Permissions]

S. Shariff, E.M. Yoshida, R.D. Gascoyne, N. Le, J.M. Connors, P.J. Middleton, and T.N. Shenkier

Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: A cross-sectional analysis
Ann Oncol 10: 961-964.
[Abstract] [PDF] [Request Permissions]

W. Wynendaele, R. Derua, M. F. Hoylaerts, A. Pawinski, E. Waelkens, E. A. de Bruijn, R. Paridaens, W. Merlevede, and A. T. van Oosterom

Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: A key to study an angiogenic marker in vivo?
Ann Oncol 10: 965-971.
[Abstract] [PDF] [Request Permissions]

Clinical case:

B. I. Rini and T. F. Gajewski

Polymyositis with respiratory muscle weakness requiring mechanical ventilation in a patient with metastatic thymoma treated with octreotide
Ann Oncol 10: 973-979.
[Abstract] [PDF] [Request Permissions]

Short reports:

K. J. O'Byrne, P. A. Philip, D. J. Propper, I. P. Braybrooke, M. P. Saunders, N. P. Bates, M. A. Taylor, D. Madigan, T. S. Ganesan, D. C. Talbot, and A. L. Harris

A phase II study of the modulation of 5-fluorouracil and folinic acid with high-dose infusional hydroxyurea in metastatic colorectal carcinoma
Ann Oncol 10: 981-983.
[Abstract] [PDF] [Request Permissions]

S. Cascinu, R. R. Silva, R. Labianca, S. Barni, R. Mattioli, G. Martignoni, L. Frontini, G. Gasparini, V. Catalano, A. M. Baldelli, L. Giuliodori, R. Agostinelli, and G. Catalano

A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer
Ann Oncol 10: 985-987.
[Abstract] [PDF] [Request Permissions]

C. H. Spiridonidis, L. R. Laufman, J. J. Jones, and V. A. Rhodes

Daily times four vinorelbine plus cisplatin in advanced non-small-cell lung cancer: A phase II trial of a novel schedule
Ann Oncol 10: 989-991.
[Abstract] [PDF] [Request Permissions]

F. Nolè, I. Minchella, M. Colleoni, E. Orvieto, E. Munzone, F. de Braud, G. Peruzzotti, G. Martinelli, M. G. Zampino, C. Catania, M. Pizzamiglio, P. Veronesi, S. Zurrida, V. Galimberti, A. Goldhirsch, and U. Veronesi

Primary chemotherapy in operable breast cancer with favorable prognostic factors: A pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)
Ann Oncol 10: 993-996.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

R. Ciotti, G. Belotti, E. Facchi, A. Cantù, A. D'Amico, and C. Gatti

Sudden cardio-pulmonary toxicity following a single infusion of gemcitabine
Ann Oncol 10: 997.
[PDF] [Request Permissions]

A. Obermair, L. Hefler, A. Nather, O. Preyer, and A. Kaider

Correlation of the serum concentration of vascular endothelial growth factor (VEGF) and hemoglobin levels in patients with epithelial ovarian cancer
Ann Oncol 10: 998.
[PDF] [Request Permissions]

I. Barista, M. Benekli, and G. Tekuzman

Amyloidosis in Hodgkin's and Castleman's diseases
Ann Oncol 10: 998-999.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.